NYSE:ALB

Albemarle Stock Forecast, Price & News

$81.61

+1.19 (+1.48 %)

(As of 09/24/2020 10:03 AM ET)

Add

Compare

Today's Range

$79.07

Now: $81.61▼

$81.71

50-Day Range

$83.34

MA: $92.73▼

$100.45

52-Week Range

$48.89

Now: $81.61▼

$101.00

Volume13,474 shs

Average Volume898,082 shs

Market Capitalization$8.68 billion

P/E Ratio19.81

Dividend Yield1.62%

Beta1.41

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The company's Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Catalysts segment offers performance catalyst solutions comprising hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was founded in 1994 and is headquartered in Charlotte, North Carolina.

Beat the Market (BTM) Rank^™

2.0 Analyst's Opinion

Consensus Rating
Albemarle has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 6 buy ratings, 13 hold ratings, and 6 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $78.18, Albemarle has a forecasted downside of 2.8% from its current price of $80.42.
Amount of Analyst Coverage
Albemarle has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.7 Community Rank

Outperform Votes
Albemarle has received 681 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Albemarle has received 581 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Albemarle has received 53.96% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote “Outperform” if you believe ALB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Yield
Albemarle pays a meaningful dividend of 1.62%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Albemarle has been increasing its dividend for 15 years.
Dividend Coverage
The dividend payout ratio of Albemarle is 25.50%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Albemarle will have a dividend payout ratio of 37.65% next year. This indicates that Albemarle will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Albemarle insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $19,508,361.00 in company stock.
Percentage Held by Insiders
Only 1.07% of the stock of Albemarle is held by insiders.
Percentage Held by Institutions
89.77% of the stock of Albemarle is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Albemarle are expected to grow by 17.19% in the coming year, from $3.49 to $4.09 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Albemarle is 19.52, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 17.74.
Price to Earnings Ratio vs. Sector
The P/E ratio of Albemarle is 19.52, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 33.33.
Price to Earnings Growth Ratio
Albemarle has a PEG Ratio of 3.40. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Albemarle has a P/B Ratio of 2.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.22 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Plastics materials & resins

Sub-IndustrySpecialty Chemicals

SectorBasic Materials

Current SymbolNYSE:ALB

Previous Symbol

CUSIP01265310

CIK915913

Webwww.albemarle.com

Phone980-299-5700

Debt

Debt-to-Equity Ratio0.74

Current Ratio1.61

Quick Ratio1.01

Price-To-Earnings

Trailing P/E Ratio19.81

Forward P/E Ratio23.38

P/E Growth3.4

Sales & Book Value

Annual Sales$3.59 billion

Price / Sales2.42

Cash Flow$6.92 per share

Price / Cash Flow11.80

Book Value$38.61 per share

Price / Book2.11

Profitability

EPS (Most Recent Fiscal Year)$6.04

Net Income$533.23 million

Net Margins12.99%

Return on Equity13.33%

Return on Assets5.73%

Miscellaneous

Employees6,000

Outstanding Shares106,360,000

Market Cap$8.68 billion

Next Earnings Date11/4/2020 (Confirmed)

OptionableOptionable

$81.61

+1.19 (+1.48 %)

(As of 09/24/2020 10:03 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

Albemarle (NYSE:ALB) Frequently Asked Questions

How has Albemarle's stock price been impacted by COVID-19?

Albemarle's stock was trading at $70.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ALB stock has increased by 14.8% and is now trading at $80.45.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Albemarle?

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 6 sell ratings, 13 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Albemarle.

When is Albemarle's next earnings date?

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Albemarle.

How can I listen to Albemarle's earnings call?

Albemarle will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) posted its quarterly earnings results on Wednesday, August, 5th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.72 by $0.14. Albemarle had a net margin of 12.99% and a return on equity of 13.33%.
View Albemarle's earnings history.

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle announced a quarterly dividend on Tuesday, July 14th. Shareholders of record on Friday, September 18th will be paid a dividend of $0.385 per share on Thursday, October 1st. This represents a $1.54 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date of this dividend is Thursday, September 17th.
View Albemarle's dividend history.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle issued an update on its third quarter 2020 After-Hours earnings guidance on Wednesday, August, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $700-775 million, compared to the consensus revenue estimate of $717.55 million.

What price target have analysts set for ALB?

25 equities research analysts have issued 1 year price targets for Albemarle's stock. Their forecasts range from $40.00 to $116.00. On average, they expect Albemarle's stock price to reach $78.18 in the next twelve months. This suggests that the stock has a possible downside of 2.8%.
View analysts' price targets for Albemarle.

Are investors shorting Albemarle?

Albemarle saw a drop in short interest in August. As of August 14th, there was short interest totaling 10,530,000 shares, a drop of 13.6% from the July 30th total of 12,190,000 shares. Based on an average trading volume of 1,180,000 shares, the short-interest ratio is currently 8.9 days. Approximately 10.0% of the company's stock are sold short.
View Albemarle's Short Interest.

Who are some of Albemarle's key competitors?

Some companies that are related to Albemarle include Sherwin-Williams (SHW), Ecolab (ECL), Valaris (VAL), Celanese (CE), International Flavors & Fragrances (IFF), RPM International (RPM), Ashland Global (ASH), NewMarket (NEU), Balchem (BCPC), Quaker Chemical (KWR), W. R. Grace & Co (GRA), Stepan (SCL), HB Fuller (FUL), Sensient Technologies (SXT) and PolyOne (POL).
View all competitors.

What other stocks do shareholders of Albemarle own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Who are Albemarle's key executives?

Albemarle's management team includes the following people:

Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
Mr. David Ryan, VP of Corp. Strategy & Investor Relations

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Who are Albemarle's major shareholders?

Albemarle's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.89%), FMR LLC (2.56%), Bank of New York Mellon Corp (2.42%), ProShare Advisors LLC (1.23%), KAMES CAPITAL plc (1.00%) and US Bancorp DE (0.88%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier.
View institutional ownership trends for Albemarle.

Which institutional investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Grantham Mayo Van Otterloo & Co. LLC, Eastern Bank, Cibc World Markets Corp, Robecosam AG, Federated Hermes Inc., Toronto Dominion Bank, and Advisor Group Holdings Inc.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, and Scott Tozier.
View insider buying and selling activity for Albemarle.

Which institutional investors are buying Albemarle stock?

ALB stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Avalon Investment & Advisory, US Bancorp DE, Marathon Asset Management LLP, Ensign Peak Advisors Inc, Zweig DiMenna Associates LLC, Perseverance Asset Management International, and Hardman Johnston Global Advisors LLC. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris.
View insider buying and selling activity for Albemarle.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $80.45.

How big of a company is Albemarle?

Albemarle has a market capitalization of $8.56 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

What is Albemarle's official website?

The official website for Albemarle is www.albemarle.com.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]

This page was last updated on 9/24/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings